Skip to content

Wound Vitality Markers in Forensic Pathology

Wound Vitality Markers in Forensic Pathology

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02892526
Acronym
PLAIES VITALES
Enrollment
57
Registered
2016-09-08
Start date
2014-12-31
Completion date
2016-12-31
Last updated
2016-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound

Brief summary

The purpose is to determine intrinsic properties of various immunohistochemical markers (FVIIIra, CD15, CD30, tryptase, TNFα, IL-1β, TGFα et TGFβ1) for diagnosis of vital wound, alone and in association (evaluation of sensibility with surgery wounds and evaluation of specificity with post-mortem wounds). Secondary purposes are to measure the minimum time to obtain a positive labeling in vital wounds, and to evaluate inter-observer reproducibility of vitality diagnosis with different markers. Expression of microRNA miR 9, miR 21 et miR 198 will be also studied.

Interventions

OTHERAbdominoplasty with exeresis of cutaneous tissue
OTHERCollection of cutaneous tissue

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Alive persons: \- Abdominoplasty Deceased persons: \- Medico-scientific autopsy for diagnosis

Exclusion criteria

Alive persons: * Fragmented sample with non-visible banks * Cutaneous pathology Deceased persons: * Persons under protection * Medico-legal obstacle * Cutaneous pathology

Design outcomes

Primary

MeasureTime frame
Sensibility of markers for vitality diagnosisbaseline
Specificity of markers for vitality diagnosisbaseline

Secondary

MeasureTime frame
Expression level of miR 9 by qRT-PCRbaseline
Minimum time to obtain a labeling (between incision and devascularization)baseline
Expression level of miR 198 by qRT-PCRbaseline
Expression level of miR 21 by qRT-PCRbaseline
Coefficient of inter-observer correlation of vitality diagnosis (for reproducibility analysis)baseline

Countries

France

Contacts

Primary ContactLaurent MARTRILLE
l.martrille@chru-nancy.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026